Shenni Holdings Limited (SNI)
| Market Cap | 165.00M |
| Revenue (ttm) | 20.52M |
| Net Income (ttm) | 3.23M |
| Shares Out | 33.00M |
| EPS (ttm) | 0.10 |
| PE Ratio | 51.16 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Range | n/a |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About SNI
Shenni Holdings, through its operating subsidiaries in China, is primarily engaged in the business of the manufacture and distribution of urology medical devices and care products as well as sales and distribution of cardiovascular and cerebrovascular medical devices. Our customers are pharmaceutical and device distributors, pharmacies and hospitals. [Read more]
News
Shenni Holdings Aims For US IPO As Business Model Is In Flux
Shenni Holdings Limited seeks to raise $15 million in an IPO to fund growth and working capital, increasing its focus on distributing third-party medical devices. The firm is growing quickly but faces...
Chinese medical device distributor Shenni Holdings files and sets terms for a $15 million US IPO
Shenni Holdings, which makes and sells urology medical devices and products in China, filed on Friday with the SEC to raise up to $15 million in an initial public offering.
Shenni Holdings IPO Registration Document (F-1)
Shenni Holdings has filed to go public with an IPO on the NASDAQ